Fluidigm Singapore launches Biomedical Product Development Centre
Singapore R&D center to develop life science instruments targeted for US$650 million market
The center's initial research activities will support the development of instrumentation for the BioMark II system. The Singapore research group will undertake 100% of the R&D on a new biochip fluorescence reader and biochip loader, specially designed for high-throughput genotyping and protein expression applications. Fluidigm Singapore will also manufacture the BioMark II system.
Operations for the Biomedical Product Development Center will commence immediately, with its current R&D team of 5. Additional staff will be recruited from Singapore's pool of manufacturing and research expertise. The R&D center will also be supported by the local precision engineering companies, academic, biomedical and pharmaceuticals research institutions.
Most read news
Organizations
Other news from the department manufacturing
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.